Literature DB >> 21767200

The accuracy of absorbed dose estimates in tumours determined by quantitative SPECT: a Monte Carlo study.

Michael Ljungberg1, Katarina Sjögreen-Gleisner.   

Abstract

BACKGROUND: Dosimetry in radionuclide therapy estimates delivered absorbed doses to tumours and ensures that absorbed dose levels to normal organs are below tolerance levels. One procedure is to determine time-activity curves in volumes-of-interests from which the absorbed dose is estimated using SPECT with appropriate corrections for attenuation, scatter and collimator response. From corrected SPECT images the absorbed energy can be calculated by (a) assuming kinetic energy deposited in the same voxel where particles were emitted, (b) convolve with point-dose kernels or (c) use full Monte Carlo (MC) methods. A question arises which dosimetry method is optimal given the limitations in reconstruction- and quantification procedures.
METHODS: Dosimetry methods (a) and (c) were evaluated by comparing dose-rate volume histograms (DrVHs) from simulated SPECT of (111)In, (177)Lu, (131)I and bremsstrahlung from (90)Y to match true dose rate images. The study used a voxel-based phantom with different tumours in the liver. SPECT reconstruction was made using an iterative OSEM method and MC dosimetry was performed using a charged-particle EGS4 program that also was used to determined true absorbed dose rate distributions for the same phantom geometry but without camera limitations.
RESULTS: The DrVHs obtained from SPECT differed from true DrVH mainly due to limited spatial resolution. MC dosimetry had a marginal effect because the SPECT spatial resolution is in the same order as the energy distribution caused by the electron track ranges. For (131)I, full MC dosimetry made a difference due to the additional contribution from high-energy photons. SPECT-based DrVHs differ significantly from true DrVHs unless the tumours are considerable larger than the spatial resolution.
CONCLUSION: It is important to understand limitations in quantitative SPECT images and the reasons for apparent heterogeneities since these have an impact on dose-volume histograms. A MC-based dosimetry calculation from SPECT images is not always warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767200     DOI: 10.3109/0284186X.2011.584559

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  18 in total

1.  VIDA: a voxel-based dosimetry method for targeted radionuclide therapy using Geant4.

Authors:  Susan D Kost; Yuni K Dewaraja; Richard G Abramson; Michael G Stabin
Journal:  Cancer Biother Radiopharm       Date:  2015-01-16       Impact factor: 3.099

2.  Accuracy of two dosimetry software programs for 177Lu radiopharmaceutical therapy using voxel-based patient-specific phantoms.

Authors:  Keamogetswe Ramonaheng; Johannes A van Staden; Hanlie du Raan
Journal:  Heliyon       Date:  2022-07-06

3.  Technetium-99m bone scan and panoramic radiography in detection of bone invasion by oral carcinoma.

Authors:  Anshuman Suresh Jamdade; Ani John
Journal:  J Clin Diagn Res       Date:  2014-05-15

Review 4.  Monte Carlo methods for device simulations in radiation therapy.

Authors:  Hyojun Park; Harald Paganetti; Jan Schuemann; Xun Jia; Chul Hee Min
Journal:  Phys Med Biol       Date:  2021-09-14       Impact factor: 4.174

Review 5.  Human Anti-Oxidation Protein A1M--A Potential Kidney Protection Agent in Peptide Receptor Radionuclide Therapy.

Authors:  Jonas Ahlstedt; Thuy A Tran; Sven-Erik Strand; Magnus Gram; Bo Åkerström
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

6.  SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy.

Authors:  Johan Gustafsson; Anna Sundlöv; Katarina Sjögreen Gleisner
Journal:  EJNMMI Res       Date:  2017-02-23       Impact factor: 3.138

Review 7.  Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools.

Authors:  Michael Ljungberg; Katarina Sjögreen Gleisner
Journal:  Biomedicines       Date:  2016-11-15

Review 8.  Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review.

Authors:  Daphne Merel Valerie Huizing; Berlinda Jantina de Wit-van der Veen; Marcel Verheij; Marcellus Petrus Maria Stokkel
Journal:  EJNMMI Res       Date:  2018-08-29       Impact factor: 3.138

9.  A 3D Monte Carlo Method for Estimation of Patient-specific Internal Organs Absorbed Dose for (99m)Tc-hynic-Tyr(3)-octreotide Imaging.

Authors:  Mehdi Momennezhad; Shahrokh Nasseri; Seyed Rasoul Zakavi; Ali Asghar Parach; Mahdi Ghorbani; Ruhollah Ghahraman Asl
Journal:  World J Nucl Med       Date:  2016 May-Aug

10.  Method dependence, observer variability and kidney volumes in radiation dosimetry of (177)Lu-DOTATATE therapy in patients with neuroendocrine tumours.

Authors:  Mattias Sandström; Ezgi Ilan; Anna Karlberg; Silvia Johansson; Nanette Freedman; Ulrike Garske-Román
Journal:  EJNMMI Phys       Date:  2015-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.